A new study details how a nasal spray formulated by investigators from Brigham and Women's Hospital may work to protect ...

MNV-201 is a mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic ...

Psychedelics biotech company Enveric Biosciences (NASDAQ: ENVB) has presented research highlighting the company's lead ...

Study found OV329 cleared and remained undetectable in the retina, eye, and brain tissues of mice, unlike vigabatrin which ...

Altogen Labs is a preclinical research organization specializing in the testing and evaluation of novel pharmacological and biological treatments, including novel anticancer therapies, medical ...

Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the ...

KT-621 has the potential to provide dupilumab-like activity with an oral small molecule profile for TH2 driven allergic and atopic diseaseKT-621 ...

Presentation of in vitro studies of RM-0256, a novel anti-PD-L1 antibody conjugated to IR700, which comprises a dual mode of photoimmunotherapy: depletion of PD-L1 expressing tumor cells and depletion ...

HOOKIPA is very pleased to present a comprehensive preclinical proof-of-concept dataset related to HB-700, for the potential treatment of KRAS mutated cancers. KRAS mutations are most frequently found ...

AUSTIN, Texas, Sept. 20, 2024 /PRNewswire/ — Altogen Labs is a preclinical research organization specializing in the testing and evaluation of novel pharmacological and biological treatments ...

The trial results indicated minimal adverse events and no evidence of immune-mediated clearance following TX45 treatment.